Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2013 Sep 23;8(9):10.1371/annotation/7f3e30b8-8dfa-4bb7-b34e-884248628454. doi: 10.1371/annotation/7f3e30b8-8dfa-4bb7-b34e-884248628454

Correction: Two Variants of the C-Reactive Protein Gene Are Associated with Risk of Pre-Eclampsia in an American Indian Population

Lyle G Best, Richa Saxena, Cindy M Anderson, Michael R Barnes, Hakon Hakonarson, Gilbert Falcon, Candelaria Martin, Berta Almoguera Castillo, Ananth Karumanchi, Kylie Keplin, Nichole Pearson, Felicia Lamb, Shellee Bercier, Brendan J Keating
PMCID: PMC3790894  PMID: 24116239

There was information omitted from the Competing Interests statement.

The information is: "Dr. Karumanchi is a co-inventor on patents related to preeclampsia diagnosis/therapy that is held by Beth Israel Deaconess Medical Center. Dr. Karumanchi also reports having served as a consultant to Beckman Coulter, Siemens, and Roche and has financial interest in Aggamin LLC."

Footnotes

Competing Interests: No competing interests declared.

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES